Navigation Links
PADRES Contra El Cancer to Host its 10th Annual Posada Holiday Celebration for Children with Cancer

GLENDALE, Calif., Dec. 10 /PRNewswire/ -- PADRES Contra El Cancer, an organization dedicated to improving the quality of life for Latino children with cancer and their families, will host its Annual Holiday Celebration for Hematology & Oncology patients this Saturday, December 13, 2008.

Children with cancer and their siblings will enjoy an afternoon playing and sledding amongst 40 tons of snow while enjoying musical performances and celebrating holiday traditions. In addition to the snow, the event will also feature arts and crafts, a traditional Mexican holiday meal, holiday family portraits, and live entertainment by Mariachi Reencuentro, Tierra Blanca Dance Company and Los Famosos del Norte.

A special appearance will be made by cancer survivor and PADRES National Spokesperson, Fernando del Rincon who will serve as the event's Master of Ceremonies. This past March del Rincon was diagnosed with cancer. Despite his condition, his support never faltered nor did his active involvement to raise awareness for the needs facing Latino children with cancer. Over the years, del Rincon has become the recognizable face behind children's issues both in the United States and abroad.

"Every year I look forward to Posada to see the smiles and laughter of the children. Their joy is the gift that I look forward to every Christmas. This year as we celebrate together, the children and I will share a special bond and a unique appreciation for life. The children are my inspiration," stated del Rincon.

Del Rincon will also be joined by Kevin Ingram, wide receiver/defensive back for the Los Angeles Avengers Football team; and Enrique Gutierrez, sports anchor for KMEX/Univision 34. Families will be greeted by Santa Claus, and the Glendale Fire Department will be on hand to distribute holiday gifts to the more than 500 pediatric cancer patients (from local hospitals including Children's Hospital Los Angeles, Los Angeles County & USC Medical Center's Women's and Children's Hospital, Mattel Children's Hospital at UCLA and Loma Linda University Children's Cancer Center).

"Posada is all about the children," said PADRES President and CEO, Elvia Barboa. "Most of the children here today were diagnosed in the past 18 months. This is our way of closing the year on a positive note celebrating the life of each child and giving their family HOPE."

PADRES Contra El Cancer (PADRES) is a non-profit organization committed to improving the quality of life for Latino children with cancer and their families. PADRES programs, activities and services, while primarily oriented to the Latino community, serve childhood cancer patients from ALL races and ethnic origins. No family is turned away. Celebrating over 20 years of service, PADRES brings together children, families, healthcare professionals and community leaders to promote a comprehensive understanding of childhood cancer and other blood disorders as well as effective methods for treatment. Please join our spokespeople Eva Longoria and Fernando del Rincon in the fight against childhood cancer. To learn more about PADRES, visit

SOURCE PADRES Contra El Cancer
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. National Spokeswoman Eva Longoria Parker to Accept $200,000 Donation From AT&T to Benefit PADRES Contra El Cancer
2. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. Exempla Healthcare Contracts For Talismans Quality Donor System
5. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
6. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
7. Healthcare Workers Ratify Contract by a 98% Vote
8. Workers Win Contract at St. Francis Medical Center
9. Jacobs Receives Contract for New Hospital Project in Belgium
10. ACS Announces Contract Extensions with Hawaii Medicaid
11. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of ... its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his ... July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with ... for the primary prevention of cardiovascular diseases during the 15th Annual Women’s ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... NJ (PRWEB) , ... October 13, 2017 , ... Global ... at scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global ... physical activity. The fun run is geared towards children of all ages; it ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Halo Labs announces the European launch of their new low ... MIBio 2017 in Cambridge, U.K on October ... biopharmaceutical samples with unprecedented speed and sensitivity while using far less ... Imaging. ... analysis system ...
(Date:9/27/2017)... 2017  Commended for their devotion to personalized service, SMP ... number one in the South Florida Business Journal,s 50 Fastest-Growing ... yearly list, the national specialty pharmacy has found its niche.  ... will soon be honored by SFBJ as the 2017 Power ... Set to receive his award in October, Bardisa said of ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: